Charles Y.F. Young

8.6k total citations
157 papers, 6.7k citations indexed

About

Charles Y.F. Young is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Charles Y.F. Young has authored 157 papers receiving a total of 6.7k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 44 papers in Pulmonary and Respiratory Medicine and 29 papers in Genetics. Recurrent topics in Charles Y.F. Young's work include Prostate Cancer Treatment and Research (42 papers), Estrogen and related hormone effects (24 papers) and Hormonal and reproductive studies (19 papers). Charles Y.F. Young is often cited by papers focused on Prostate Cancer Treatment and Research (42 papers), Estrogen and related hormone effects (24 papers) and Hormonal and reproductive studies (19 papers). Charles Y.F. Young collaborates with scholars based in United States, South Africa and China. Charles Y.F. Young's co-authors include Donald J. Tindall, Donkena Krishna Vanaja, Huiqing Yuan, John C. Cheville, Patricia E. Murtha, Benjamin T. Montgomery, D. J. Tindall, Krishna Vanaja Donkena, Paul E. Andrews and Rachel Butler and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Charles Y.F. Young

157 papers receiving 6.5k citations

Peers

Charles Y.F. Young
Mark Thornquist United States
Karl E. Anderson United States
Gail P. Jarvik United States
Elizabeth G. Nabel United States
Lori M. Minasian United States
Peter H. Gann United States
Barbara A. Parker United States
David B. Agus United States
Charles Y.F. Young
Citations per year, relative to Charles Y.F. Young Charles Y.F. Young (= 1×) peers Kjell Grankvist

Countries citing papers authored by Charles Y.F. Young

Since Specialization
Citations

This map shows the geographic impact of Charles Y.F. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Y.F. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Y.F. Young more than expected).

Fields of papers citing papers by Charles Y.F. Young

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Y.F. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Y.F. Young. The network helps show where Charles Y.F. Young may publish in the future.

Co-authorship network of co-authors of Charles Y.F. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Y.F. Young. A scholar is included among the top collaborators of Charles Y.F. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Y.F. Young. Charles Y.F. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grippin, Adam, Brian De, Katharina Fink, et al.. (2023). MA15.04 Timing of Pre-Biopsy COVID-mRNA Vaccination and PD-L1 Expression in Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 18(11). S153–S154. 1 indexed citations
2.
Young, Charles Y.F., et al.. (2022). Exploring patterns of Facebook usage, social capital, loneliness and well-being among a diverse South African student sample. SHILAP Revista de lepidopterología. 33(1). 57–72. 2 indexed citations
3.
Macleod, Catriona Ida, et al.. (2021). Alcohol use during pregnancy: prevalence and patterns in selected Buffalo City areas, South Africa.. African Journal of Reproductive Health. 25(1). 114–121. 4 indexed citations
4.
Bisson, Jonathan I., Robert William Martin Van Deursen, Ben Hannigan, et al.. (2020). Randomized controlled trial of multi‐modular motion‐assisted memory desensitization and reconsolidation (3MDR) for male military veterans with treatment‐resistant post‐traumatic stress disorder. Acta Psychiatrica Scandinavica. 142(2). 141–151. 27 indexed citations
5.
Wu, Qiang, Manish Kohli, H. Robert Bergen, et al.. (2014). Preclinical Evaluation of the Supercritical Extract of Azadirachta Indica (Neem) Leaves In Vitro and In Vivo on Inhibition of Prostate Cancer Tumor Growth. Molecular Cancer Therapeutics. 13(5). 1067–1077. 29 indexed citations
6.
Zhang, Denglu, Yazhou Cui, Leilei Niu, et al.. (2014). Regulation of SOD2 and β-arrestin1 by interleukin-6 contributes to the increase of IGF-1R expression in docetaxel resistant prostate cancer cells. European Journal of Cell Biology. 93(7). 289–298. 17 indexed citations
7.
Young, Charles Y.F., et al.. (2013). Experiences of sexual relationships of young black women in an atmosphere of coercion : original article. 10(1). 8–16. 1 indexed citations
8.
Mahapatra, Saswati, Eric W. Klee, Charles Y.F. Young, et al.. (2012). Global Methylation Profiling for Risk Prediction of Prostate Cancer. Clinical Cancer Research. 18(10). 2882–2895. 100 indexed citations
9.
Zhang, Yuexing, Douglas E. Linn, Zhenqiu Liu, et al.. (2008). EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance. Molecular Cancer Therapeutics. 7(10). 3176–3186. 51 indexed citations
10.
Young, Charles Y.F.. (2007). Recent Approaches in Chemoprevention of Prostate Cancer. Current Cancer Drug Targets. 7(7). 681–688. 1 indexed citations
11.
Chung, Byung Ha, et al.. (2005). Perillyl alcohol inhibits the expression and function of the androgen receptor in human prostate cancer cells. Cancer Letters. 236(2). 222–228. 36 indexed citations
12.
Pan, Yunqian, et al.. (2003). The cyclooxygenase 2-specific nonsteroidal anti-inflammatory drugs celecoxib and nimesulide inhibit androgen receptor activity via induction of c-Jun in prostate cancer cells.. PubMed. 12(8). 769–74. 37 indexed citations
13.
Liu, Jie, Jin‐San Zhang, Charles Y.F. Young, & Pai C. Kao. (2003). Polymorphisms of prostate-specific antigen gene promoter: determination from cord blood collected on filter paper.. PubMed. 33(4). 429–34. 3 indexed citations
14.
Spitzweg, Christine, Michael K. O’Connor, Elizabeth R. Bergert, et al.. (2000). Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.. PubMed. 60(22). 6526–30. 180 indexed citations
15.
Spitzweg, Christine, Shaobo Zhang, Elizabeth R. Bergert, et al.. (1999). Prostate-specific antigen (PSA) promoter-driven androgen-inducible expression of sodium iodide symporter in prostate cancer cell lines.. PubMed. 59(9). 2136–41. 154 indexed citations
16.
Butler, Rachel, et al.. (1998). Induction of apoptosis in prostate cancer cell lines by the green tea component, (−)-epigallocatechin-3-gallate. Cancer Letters. 130(1-2). 1–7. 247 indexed citations
17.
Corey, Eva, Edward W. Arfman, Sebastian Melchior, et al.. (1997). Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) Messages. Urology. 50(2). 184–188. 56 indexed citations
18.
Grauer, Lana S., M. Cristine Charlesworth, Mohammad S. Saedi, et al.. (1996). Identification of Human Glandular Kallikrein hK2 From LNCaP Cells. Journal of Andrology. 17(4). 353–359. 25 indexed citations
19.
Tang, Paul C., J. Annevelink, Henri J. Suermondt, & Charles Y.F. Young. (1994). Semantic integration of information in a physician's workstation. International Journal of Bio-Medical Computing. 35(1). 47–60. 9 indexed citations
20.
Andrews, Paul E., Charles Y.F. Young, Benjamin T. Montgomery, & D. J. Tindall. (1992). Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line.. PubMed. 52(6). 1525–9. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026